Get the weekly research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean. No account.
Any unsolicited idea or intellectual property submission made to the company automatically becomes company property, with no compensation to the submitter, no confidentiality obligation, and no restriction on the company's right to use, redistribute, or develop competing products based on the submission.
This analysis describes what UnitedHealthcare's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision asserts that unsolicited submissions transfer automatically to company ownership with no compensation or confidentiality obligation, and explicitly permits the company to develop competing products based on such submissions. The clause operates regardless of any contrary statements made in the submission itself.
Interpretive note: Enforceability of automatic assignment of submitted ideas as company property may depend on whether adequate prior notice of this policy was provided and may vary by jurisdiction.
Under this clause, any ideas or intellectual property submitted to the company outside of a formal agreement become company property automatically, with no duty of confidentiality and no compensation obligation. The agreement advises submitters to consult legal counsel before making submissions if they have intellectual property concerns.
Cross-platform context
See how other platforms handle Unsolicited Idea Submission Policy and similar clauses.
Compare across platforms →Monitoring
UnitedHealthcare has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"If you still choose to make any submission to us, you agree as follows, regardless of any statements made in your submission that: We owe you no compensation; There is no duty of confidentiality between us and you; Your submission automatically becomes our property, and we may use or redistribute the contents of that submission in any way for any purpose; We are free to acquire, develop, and sell services and products that may be competitive to those you offer or suggest; and It is your responsibility to protect your own intellectual property; you should not make a submission to us if you have concerns about intellectual property.Excerpt from UnitedHealthcare's Terms of Use
(1) REGULATORY LANDSCAPE: This provision engages intellectual property law, including trade secret protection under the Defend Trade Secrets Act and applicable state trade secret statutes. The clause explicitly states there is no confidentiality obligation, which may affect the submitter's ability to claim trade secret protection over submitted materials if they were previously undisclosed. (2) GOVERNANCE EXPOSURE: Low to Medium. The provision is a common structural mechanism in corporate intellectual property policies, but the explicit assertion of automatic ownership transfer and the permission to develop competing products are notable in scope. Enforceability may depend on whether the submitter had prior notice of this policy before making the submission. (3) JURISDICTION FLAGS: The enforceability of automatic assignment clauses over ideas submitted without a formal contract may face scrutiny in jurisdictions with heightened intellectual property protections. The clause applies regardless of any contrary statements in the submission. (4) CONTRACT AND VENDOR IMPLICATIONS: Business partners, vendors, or individuals considering submitting product or technology ideas to UnitedHealthcare outside of formal procurement or vendor agreements should assess this provision against their intellectual property protection strategies. (5) COMPLIANCE CONSIDERATIONS: The document itself recommends consulting legal counsel before making a submission, which implicitly acknowledges the legal complexity of this provision. Compliance teams handling inbound unsolicited submissions should maintain records confirming the applicability of this policy.
Full institutional analysis
Regulatory citations, enforcement risk, and due diligence action items.
Monitor: same-day alerts on the platforms you choose. Analyst: full institutional analysis.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision asserts that unsolicited submissions transfer automatically to company ownership with no compensation or confidentiality obligation, and explicitly permits the company to develop competing products based on such submissions. The clause operates regardless of any contrary statements made in the submission itself.
Under this clause, any ideas or intellectual property submitted to the company outside of a formal agreement become company property automatically, with no duty of confidentiality and no compensation obligation. The agreement advises submitters to consult legal counsel before making submissions if they have intellectual property concerns.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by UnitedHealthcare.